| P/E (FY) | — | Sales (TTM) | $40.6M |
| Earnings (TTM) | -$29.1M | ROE | −95.64% |
| Net Margin | −69.08% | ROIC | −104.72% |
| Debt / Equity | 1.75 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 21.62% |
ClearPoint Neuro is a commercial-stage medical device company focused on platforms for minimally invasive surgical procedures in the brain in the United States. Its ClearPoint systems include hardware such as head fixation frames, workstations, and monitors; disposables like the SmartFrame trajectory device and SmartFlow Neuro cannula; and software for surgical planning, navigation, and procedure monitoring. It also offers the Prism Neuro laser therapy and IRRAflow fluid-exchange systems, plus consulting services.
| Market Cap | $435.7M | Trading Days | 3520 |
| 52W High | 30.10 |
| 52W Low | 8.27 |
| % Off High | −51.73% |
| YTD | 6.21% | 1Y | 32.45% |
| 3Y | 125.62% | 5Y | −27.35% |
| 10Y | 45.45% | Since incept. (ann.) | −5.02% |
Product 21% · Biologics And Drug Delivery 17% · Neurosurgery Navigation And Therapy Disposable Products 13% · Neurosurgery Navigation And Therapy 13% · …
| Ann. Volatility (1Y) | 105.00% | Ann. Volatility (3Y) | 86.64% |
| Sharpe (1Y) | 0.75 | Sharpe (3Y) | 0.72 |
| Max Drawdown (1Y) | −70.74% | Max Drawdown (3Y) | −70.74% |
| Beta (3Y, vs SPY) | 1.84 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| PMI | Picard Medical, Inc. | $405.8M | — |
| DCTH | DELCATH SYSTEMS, INC. | $398.7M | 165.0 |
| OFIX | Orthofix Medical Inc. | $495.6M | — |
| SI | SHOULDER INNOVATIONS, INC. | $502.9M | — |
| KIDS | ORTHOPEDIATRICS CORP | $509.6M | — |
| MOBI | Mobia Medical, Inc. | $370.1M | — |
| NPCE | NeuroPace Inc | $521.6M | — |
| CARL | CARLSMED, INC. | $334.6M | — |
| CERS | CERUS CORP | $585.1M | — |
| ANGO | ANGIODYNAMICS INC | $592.7M | — |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $625.7M | 33.8 |
| PLUS THERAPEUTICS, INC. |
| $292.5M |
| — |
